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Abstract
Alcohol is metabolized in the liver via the enzymes alcohol dehydrogenase (ADH) and alde-
hyde dehydrogenase (ALDH). Polymorphisms in the genes encoding these enzymes, which
are common in East Asian populations, can alter enzyme kinetics and hence the risk of alco-
hol dependence and its sequelae. One of the most important genetic variants, in this
regards, is the single nucleotide polymorphism (SNP) rs671 in ALDH2, the gene encoding
the primary acetaldehyde metabolizing enzyme ALDH2. However, the protective allele of
rs671 is absent in most Europeans although ALDH1B1, which shares significant sequence
homology with ALDH2, contains several, potentially functional, missense SNPs that do
occur in European populations. The aims of this study were: (i) to use bioinformatic tech-
niques to characterize the possible effects of selected variants in ALDH1B1 on protein struc-
ture and function; and, (ii) to genotype three missense and one stop-gain, protein-altering,
non-synonymous SNPs in 1478 alcohol dependent cases and 1254 controls of matched
British and Irish ancestry. No significant allelic associations were observed between the
three missense SNPs and alcohol dependence risk. The minor allele frequency of
rs142427338 (Gln378Ter) was higher in alcohol dependent cases than in controls (allelic
P = 0.19, OR = 2.98, [0.62–14.37]) but as this SNP is very rare the study was likely under-
powered to detect an association with alcohol dependence risk. This potential association
will needs to be further evaluated in other large, independent European populations.
Introduction
Alcohol is metabolized in the liver to acetaldehyde and acetate via the enzymes alcohol dehy-
drogenase (ADH) and aldehyde dehydrogenase (ALDH). Functional polymorphisms in the
genes encoding ADH and ALDH are associated with alterations in enzyme kinetics [1, 2],
which, in turn, may determine the rates of production and removal of the toxic intermediate
metabolite acetaldehyde. High circulating acetaldehyde concentrations are associated with a
number of unpleasant systemic effects, including: facial flushing, tachycardia, nausea,
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headache and even collapse and death [3, 4]. In consequence, individuals carrying certain
functional ADH and ALDH variants tend to limit their alcohol consumption and so are, in
effect, protected from developing alcohol dependence and the medical consequences of harm-
ful drinking [5–8].
There are significant differences in the frequencies of these functional ADH and ALDH var-
iants between ethnic groups. The prevalence of these variants is higher in the Far East and very
much lower in Europe. Thus, for example, the missense single nucleotide polymorphism
(SNP) rs1229984 (Arg48His) in ADH1B, which increases the maximal velocity at which alco-
hol is oxidized to acetaldehyde by over 100-fold [3, 9], is found in 19 to 91% of East-Asians
and 10 to 70% of West-Asians [7], but at rates ranging from zero to 10% in other populations
[10,11]. Nevertheless, there is consistent evidence that the protection against the development
of alcohol dependence conferred by carriage of this variant extends to these populations as
well [7,12–15].
Similarly, a missense SNP, rs671 (Glu504Lys) in ALDH2, which inactivates the mitochon-
drial isoform of ALDH2 causing a loss of up to 90% of its enzymatic activity and 20-fold eleva-
tions in circulating acetaldehyde levels following alcohol consumption, is found in 30 to 50%
of East-Asians [16] but is absent in Europeans [17]. However, other genes, for example
ALDH1B1, have the capacity to oxidize acetaldehyde at physiologically relevant rates [18] and
may be of importance in relation to alcohol dependence in European populations. ALDH1B1
is located on chromosome 9 and its encoded protein, ALDH1B1, has 75% amino acid sequence
homology with ALDH2. In addition, in common with ALDH2, it is expressed in liver mito-
chondria and is predicted to form homo-tetramers comprised of four ALDH1B1 monomer
subunits [18]. Computational analysis predicts that ALDH1B1 monomer subunits preferen-
tially hetero-tetramerize with ALDH2 rather than forming homo-tetramers amongst them-
selves; this provides a hypothetical explanation for why inactivation of ALDH2 in carriers of
the ALDH2 504Lys allele is not compensated for by ALDH1B1 [19].
A number of missense SNPs have been identified in ALDH1B1, which are thought likely to
alter the structure of its protein product the enzyme ALDH1B1 [20–22]. Jackson et al [19],
undertook computational modelling of human recombinant ALDH1B1 and investigated the
functional effects of three non-synonymous SNPs in ALDH1B1 viz: rs2073478 (Arg107Leu),
rs2228093 (Ala86Val) and rs4878199 (Val253Met) in vitro. They showed that presence of the
Val86 allele of rs2228093 abolished enzyme activity whereas the other two SNPs appeared to
have no effect. The association between two of these SNPs, rs2073478 (Arg107Leu) and
rs2228093 (Ala86Val) and alcohol consumption levels and the risk for developing alcohol
dependence has been explored but with no robust or replicated findings [20,23–25]. Thus,
there is some functional evidence suggesting that non-synonymous SNPs in ALDH1B1 might
affect enzyme activity and hence alcohol metabolism. There is also limited and conflicting
genetic evidence for their role in modifying the risk for developing alcohol dependence in
man.
The primary aims of this study were: (i) to use bioinformatic techniques to identify and
characterize non-synonymous SNPs in ALDH1B1; and, (ii) to investigate, using a case control
design, whether these functional variants associate with alcohol dependence risk in a large,
carefully characterized population of British and Irish ancestry.
Materials and methods
Bioinformatic analysis
Selecting variants in ALDH1B1. A search for nonsense variants with any notated fre-
quency, and missense variants with minor allele frequencies (MAF) exceeding 5% in
ALDH1B1 and alcohol dependence risk in a British and Irish population
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populations of European ancestry was undertaken in the 1000 Genomes Project build 37 phase
I integrated data in the relevant region (chr9: 38,395,746–38,397,299) [21].
Four, non-synonymous variants fulfilled the selection criteria: three were missense variants;
rs2073478 (Arg107Leu), rs2228093 (Ala86Val) and rs4878199 (Val253Met); and one stop/gain
variant, rs142427338 (Gln378Ter). These variants are common in the reference 1000 genomes
European ancestry sub-populations [21]. The allele frequencies for rs2073478 (Arg107Leu)
and rs2228093 (Ala86Val) are largely similar in the British, Toscani and Iberian groups, with
the frequency distributions in the Finnish group varying most noticeably from the rest (S1
Fig).
Missense variant functionality prediction. The likelihood that the three missense vari-
ants were damaging was investigated using the functional prediction software PolyPhen-2
[26]; rs2073478 (Arg107Leu) and rs2228093 (Ala86Val) were predicted to be damaging while
the mutation in the third, rs4878199 (Val253Met) was predicted to be benign (Table 1). This
software cannot be used to predict the potential damaging effects of loss of function variants,
such as rs142427338 (Gln378Ter), as the rare allele of this SNP encodes a stop codon.
Structural homology modelling. Structural homology models of the monomeric unit of
wild type ALDH1B1 (GI: 25777730) were generated using the I-TASSER computational
modelling server [27–29]. The top ranked homology model was derived from an alignment
with the human ALDH2 protein structure (PDB 1a4zA) (S1 Table). The accuracy of this
model was estimated by the I-TASSER server using the topology modelling score [30]. It was
subsequently visualized using UCSF Chimera [31]. The model of the wild-type ALDH1B1 was
subsequently modified by introducing relevant amino acid substitutions using the rotamer
function of UCSF Chimera [31] to allow visualization of the positioning of the three missense
variants within the overall structure.
Homology modelling was also used to visualize the structural effects of the stop gain variant
rs142427338 (Gln378Ter) and hence the potential damaging effects of this SNP.
Molecular dynamic simulations. Molecular dynamics simulations were performed on
both the wild-type and the rs2228093 (Ala86Val) variant ALDH1B1 homology models using
GROMACS 5.0 [32, 33]; the rs2228093 variant was selected for study as it is predicted to be the
most damaging of the three missense SNPs. The force-field used in all simulations was
OPLA-AA/L all-atom force field [34]. The structures were immersed in cubic boxes
(size = 10.8 nm3) containing 39842 water molecules. Sodium ions were added for charge neu-
tralization. The Particle Mesh Ewald method [35] was used to treat long range electrostatic
interactions and the structures relaxed through steepest descent energy minimization runs
until the maximum force was less than 1000 kJ.mol-1.nm-2. The solvent and ions were then
equilibrated with the starting structure through two steps of molecular dynamics equilibration
runs. The first equilibration was run with a constant number of particles, volume and tempera-
ture (NVT) over a period of 100 picoseconds; the presence of a stable temperature profile
Table 1. PolyPhen-2* functional prediction analysis of the three ALDH1B1 missense variants.
SNP identity Amino acid change PolyPhen-2 score
(0–1)
PolyPhen-2 prediction
rs2073478 Arg107Leu 0.46 Possibly damaging
rs2228093 Ala86Val 0.99 Probably damaging
rs4878199 Val253Met 0 Benign
*Adzhubei et al., 2010 [26]
Abbreviations: SNP = single nucleotide polymorphism
https://doi.org/10.1371/journal.pone.0177009.t001
ALDH1B1 and alcohol dependence risk in a British and Irish population
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throughout the run confirmed equilibrium. The second equilibration was run with a constant
number of particles, pressure and temperature (NPT) over a period of 100 picoseconds; the
presence of stable pressure and density over the run confirmed equilibrium. The final produc-
tion runs of the molecular dynamics were performed over 100 nanoseconds under NPT
conditions.
Trajectory analysis. The atomic movements within the output trajectory files from the
molecular dynamics simulations were analyzed by root mean square deviation (RMSD) and
root mean square fluctuation (RMSF) analyses as performed in GROMACS 5.0 [32,33].
RMSF values were calculated between time points of the simulation at equlibrium indicated
by a plateau in the trace of the RMSD trajectories. The RMSD and RMSF values of the variant
and wild-type structures were directly compared by visualization of the data points over the
entire 100 ns of simulation or the amino-acid sequence of ALDH1B1, respectively. The
RMSD and RMSF values were also compared by their average values (mean ±1 standard
deviation). Trajectories were animated using visual molecular dynamics (VMD) software
[36].
Genetic association study
Alcohol dependent cases. Individuals attending a variety of UK community and hospital-
based services providing support and treatment for alcohol use disorders, between 1997 and
2014, were screened for eligibility. They were included in the study if: (i) they met the criteria
for alcohol dependence specified in the Diagnostic and Statistical Manual of Mental Disorders,
4th Edition (DSM-IV) [37] or the International Statistical Classification of Diseases and Related
Health Problems, 10th Revision (ICD-10) [38]; (ii) if they were of English, Scottish, Welsh or
Irish but not Jewish descent with a maximum of one grandparent of European ancestry; and,
(iii) they were not related to any of the other included subjects.
Controls. Ancestrally-matched controls were recruited from London branches of the
National Health Service (NHS) blood transfusion service, from General Practitioners’ surger-
ies, from amongst university students, and from the general public through the National
Institute of Health Research (NIHR) funded Mental Health Research Network (MHRN). Indi-
viduals were excluded if they met the schedule for affective disorders and schizophrenia life-
time version (SADS-L) criteria for a history of depression, bipolar disorder, schizophrenia or
alcohol/drug use disorders [39]; none of the control subjects had a family history of bipolar
disorder, schizophrenia or alcohol dependence; none currently drank alcohol above a weekly
maximum of 168 g for men or 112 g for women, nor had done so at any time in the past. In
addition, DNA from a separate set of controls of British ancestry, not screened for psychiatric
or alcohol use disorders, was purchased from the European Collection of Cell Cultures
(ECACC; Health Protection Agency Culture Collections, Salisbury, UK).
None of the cases or controls utilized in this study had participated in any previous studies
on ALDH genes polymorphisms or in GWAS studies of alcohol dependence.
DNA extraction and genotyping. Genomic DNA was extracted from whole blood from
using a standard cell lysis, phenol chloroform technique [40]. The ECACC DNA was pre-
extracted from transformed lymphoblastoid cell lines.
Primers for genotyping were designed using PrimerPicker software (http://www.lgcgroup.
com/genotyping/) (Table 2). Genotyping for the ALH1B1 SNPs was carried out, in-house,
using fluorescent competitive allele specific PCR reagents (KASPar; LGC Genomics, Hoddes-
don, UK). Amplification and detection was undertaken using a LightCycler1 480 real time
PCR system (Roche Applied Science, Burgess Hill, UK). Genotype calling was performed
automatically by built-in Roche software of cluster plots with some manual editing of calls.
ALDH1B1 and alcohol dependence risk in a British and Irish population
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Approximately 12% of samples, randomly selected a priori, were genotyped in duplicate to
ensure consistent allele calling.
Sequencing of rs142427338. Samples identified as carrying the minor allele of the stop
gain variant rs142427338 (Gln378Ter), together with samples of uncertain genotype for this
SNP, were directly sequenced in order to validate the KASPar genotype calling. Sequencing
primers were designed using Primer-BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-
blast/) (Forward–CTGACATGGAGCATGCCGT; Reverse–CAGATCCCGGGTGAACACAG). A
standard touchdown PCR protocol was performed [41] on 25ng of genomic DNA using a
GeneAmp PCR System 9700 machine (Invitrogen, Paisley, UK) with an increased annealing
temperature of 68˚C to prevent non-specific amplification. PCR amplification success and
specificity were determined by visualizing the fragments with agarose gel electrophoresis.
Amplified PCR templates were cleaned using PEG precipitation (0.5M NaCl, 1 mM Tris-HCl
pH 8.0, 0.1 mM EDTA, PEG 8000 20%, 1.75 mM MgCl2) prior to sequencing. Sequencing
reactions were performed using a BigDye terminator kit (Applied Biosystems1; Haywards
Heath; UK) with an ABI 3730xl DNA Analyzer (Applied Biosystems1, Life Technologies, Cali-
fornia; USA). Sequencing data were read and analyzed using the Staden package [42].
Data analysis. Test for primary allelic associations, missingness, deviation from Hardy-
Weinberg equilibrium (HWE) and linkage disequilbrium were performed using PLINK ver-
sion 1.9 [43,44]. Samples with conflicting calls (<0.05% of total) were excluded from further
analyses.
Ethics
United Kingdom National Health Service Multicentre Research Ethics Committee approval
was granted for this study (MREC/03/11/090). This was ratified by the Research and Develop-
ment Departments associated with the individual participating centres. Written informed con-
sent was obtained from all subjects prior to inclusion.
Table 2. Primers used for genotyping the four selected SNPs in ALDH1B1.
SNP identity Sequence of primers
rs2073478 GAAGGTGACCAAGTTCATGCTCCACTAGGTCTGCCAGGC
GAAGGTCGGAGTCAACGGATTGCTCCACTAGGTCTGCCAGGA
GGTCCCCATGGCGCCGGAT
AGCGGGGCCGGCTGCTGAA
rs2228093 GAAGGTGACCAAGTTCATGCTGTGAAAGCAGCCCGGGAAGC
GAAGGTCGGAGTCAACGGATTCGTGAAAGCAGCCCGGGAAGT
GAGGCATCCATCCGGCGCCAT
CATGGGGACCCCAGGCGGAA
rs4878199 GAAGGTGACCAAGTTCATGCTGAAGGCAACTTTGTCAACATCCAC
GAAGGTCGGAGTCAACGGATTGTGAAGGCAACTTTGTCAACATCCAT
GTGCGGCCATCGCCCAGCA
CCCAACAGCAGGTGCGGCCAT
rs142427338 GAAGGTGACCAAGTTCATGCTAGGCTACATCCAGCTTGGCC
GAAGGTCGGAGTCAACGGATTCTAGGCTACATCCAGCTTGGCT
GCTCTCCGCCACAGAGGAGTTT
CAGAGGAGTTTTGCGCCCTCCTT
Abbreviations: SNP = Single nucleotide polymorphism
https://doi.org/10.1371/journal.pone.0177009.t002
ALDH1B1 and alcohol dependence risk in a British and Irish population
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Results
Bioinformatic analysis
Predicted Structure of ALDH1B1. The top ranked predicted structure for the ALDH1B1
monomeric unit had a 95% structural overlap and 76% amino acid sequence identity with the
ALDH2 structure 1A4Z. The estimated template modelling score between the homology
model structure and the undetermined native structure was 0.69 ± 0.12.
The key structural features of the predicted ALDH1B1 monomer subunit were: (i) a dinu-
cleotide binding domain; (ii) an oligomerization domain; and, (iii) a catalytic domain (Fig 1A;
S1 Video). The three missense variants rs2073478 (Arg107Leu), rs2228093 (Ala86Val) and
rs4878199 (Val253Met) are predicted to locate to the co-enzyme domain facing the outer sur-
face of the enzyme (Fig 1A). The nonsense variant rs142427338 (Gln378Ter) is predicted to
result in a premature transcription termination codon within ALDH1B1 and hence loss of 139
amino acids in the catalytic domain of the enzyme crucial for its function (Fig 1B).
Molecular dynamics simulations. The RMSD of the carbon αbackbone of the wild-type
ALDH1B1 monomer indicates that the structures attained equilibrium deviation after 10 ns
(Fig 2A). The RMSF indicates that this monomer contains four major regions of structural
flexibility viz: (i) a region around residues 1–17 in the N-terminal, which lies within the mito-
chondrial targeting sequence of the enzyme; (ii & iii) two regions around residues 150–170
and 510–517 which, despite being distant in the primary sequence, are sterically close within
the monomer structure and encompass the majority of the oligomerization domain; and, (iv) a
Fig 1. Homology model structure of the wild-type ALDH1B1 primary sequence (GI: 25777730). This model structure is annotated and rotated
to illustrate the positionings of: A) the three misssense variants; and, B) the stop codon variant.
https://doi.org/10.1371/journal.pone.0177009.g001
ALDH1B1 and alcohol dependence risk in a British and Irish population
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region around residues 270–280 which contains an alpha-helix αD, which is a key component
of the dinucleotide binding domain within the Rossman fold (Fig 2B; S1 Video).
The simulation trajectory of the Val86 variant monomer differed from that of the wild type
(average RMSD ± SD = 0.44 ± 0.055 nm vs. average RMSD ± SD = 0.35 ± 0.034 nm respec-
tively), suggesting that the Val86 substitution reduces the structural stability in silico. The
RMSF data generally mirrored those of the wild-type, except for: (i) a reduction in the flexibil-
ity between residues in positions 150–170, which correspond to a region of the oligomerization
domain; and, (ii) an increase of the flexibility between residues in positions 270–280, which
correspond to a key component of the dinucleotide binding domain.
Fig 2. Molecular dynamics simulations performed on the structural homology models of the wild type and the 86Val variant structure of
ALDH1B1. A—The RMSD* of carbon α backbone atoms over the course of the entire 100 ns molecular dynamics simulation for the wild-type (blue) and
Val86 variant (red) structure. B—The RMSF** of carbon α backbone atoms over the last 90 ns of the molecular dynamics simulation for the wild-type (blue)
and Val86 variant (red) structure. * The root mean squared deviation (RMSD) is a measure the average distance between a number of atomistic positions
between a reference structural model and the structural model at a point in time during the simulation. Its variability over the time-course of the simulation
indicates the scale of atomistic movement in a structural model and whether it has achieved dynamic equilibrium. ** The root mean squared fluctuation
(RMSF) is a calculation of the average RMSD in a well-defined atomistic position, typically atoms present in key regions of the protein structure, over a
specified time-period of the simulation. The RMSF highlights differences in movement between in a protein structure over a time period of a simulation and is
useful for comparing two or more simulation trajectories.
https://doi.org/10.1371/journal.pone.0177009.g002
ALDH1B1 and alcohol dependence risk in a British and Irish population
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Genetic association analysis
Genotyping accuracy. Genotyping was completed for all four SNPs with call rates all
greater than 95%. All markers followed Hardy Weinberg Equilibrium (HWE; cut-off > 0.05)
in cases and controls.
Primary allelic associations of ALDH1B1 SNPs. A total of 1478 alcohol dependent cases
and 1254 controls were genotyped.
No significant differences were observed in the frequencies of the three missense ALDH1B1
SNPs between the cases and controls (Table 3). However, the prevalence of the allele of the
rare rs142427338 (Gln378Ter) was higher in the cases (allelic = 0.19, odds ratio [OR] = 2.98,
95% confidence interval [CI] 0.62–14.37) (Table 3). The variants were in strong linkage
disequlibrium.
Discussion
The missense variant rs671 in ALDH2 significantly affects the risk of developing alcohol
dependence and its sequelae in East Asian populations but this variant is largely absent in
European populations. There is, however, significant sequence homology between ALDH2
and ALDH1B1 and similarities in their enzymes cellular positioning within the mitochondrion
and in their tendency to forms homo-tetramers in vitro. Importantly, however, ALDH1B1,
unlike ALDH2, contains several missense SNPs which are common in European populations.
Nevertheless, it is unclear whether these variants affect the processing of acetaldehyde, and
hence influence the risk of developing the adverse consequences associated with alcohol con-
sumption. This was addressed in the present study, in which four non-synonymous variants in
ALDH1B1, three missense and one stop gain, which result in changes to the primary sequence
of ALDH1B1, were further characterized using functional prediction software, structural
homology modelling and molecular dynamics simulation.
The structure of the ALDH1B1 monomer subunit was predicted using the top-ranked
I-TASSER software [28]. The output metrics for the final homology model provided a high
degree of confidence in the prediction [30]. The technique of molecular dynamics simulation
Table 3. Single marker allelic associations for genotyped ALDH1B1 polymorphisms in alcohol dependent cases and controls.
SNP Cohort Number Minor allele Genotype counts MAF (%) Significance
(P value)*
OR
(95% CI)
rs2073478 TT TG GG
Case 1446 G 508 698 240 40.7 0.75 (1) 1.03 (0.88–1.20)
Control 1244 433 604 207 40.9
rs2228093 CC CT TT
Case 1450 T 1080 346 24 13.6 0.91 (1) 0.99 (0.89–1.11)
Control 1245 939 282 24 13.3
rs4878199 AA AG GG
Case 1415 G 1299 114 2 4.2 0.42 (1) 0.90 (0.69–1.17)
Control 1232 1122 106 4 4.6
rs142427338 CC CT TT
Case 1472 T 1466 6 0 0.2 0.19 (0.77) 2.98 (0.62–14.37)
Control 1252 1250 2 0 0.1
Abbreviations: SNP = Single Nucleotide Polymorphism; MAF = Minor Allele Frequency; χ2 = Chi-squared statistic; OR = Odds Ratio; CI = Confidence
Intervals.
*The unadjusted significance value of an allelic Fishers exact test; the value in brackets has been adjusted for multiple testing using Bonferroni correction.
https://doi.org/10.1371/journal.pone.0177009.t003
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was used to infer the flexibility of this predicted ALDH1B1 structure and characterize the
effects of the 86Val allelic variant on protein structure and function [45,46]. The simulations
revealed four regions of flexibility. The first, located at the N-terminal of the protein (residues
1–17), encompassed the mitochondrial targeting sequence. The simulated flexibility in this
mitochondrial targeting sequence agrees with Nuclear Magnetic Resonance (NMR) and crys-
tallography studies, which have experimentally determined freedom of movement in this
region in homologous ALDH proteins [47,48]. The second and third regions of flexibility (resi-
dues 150–170 and 510–517) lie in the oligomerization domain of ALDH1B1. Flexibility in this
domain might reflect the fact that the simulation left this region exposed whereas in the puta-
tive ALDH1B1 tetramer the oligomerization domain would likely be buried and hence stabi-
lized within the overall macromolecular structure. The fourth region of flexibility (residues
270–280) contains an alpha-helix αD which is a key component of the dinucleotide binding
domain. Structural studies of the homologous alpha-helix in ALDH2 comparing the apo and
holo forms of the enzyme, have shown that movement of this alpha-helix is essential for
isomerization of bound NAD, a significant and necessary feature of catalysis [49].
A comparison of the molecular dynamics trajectory of the predicted structures of the wild-
type ALDH1B1 and the missense variant predicted to be most damaging viz. rs2228093
(Ala86Val) demonstrates a considerable increase in the flexibility of the 270 to 280 region. As
this region of the protein is crucial for the binding of the coenzyme NAD, this observation
could explain the catalytic inactivity of this variant previously observed in vitro [19]. Ulti-
mately, however, this technique does not provide conclusive evidence of a functional effect of
this genetic variant on protein structure but does provide a basis for later confirmation by X-
ray crystallography or solution NMR. This, not withstanding, other studies have reported [50]
excellent correlations between molecular dynamics simulation and experimental data.
The variant, rs142427338 (Gln378Ter) in ALDH1B1 encodes a stop codon rather than
another amino-acid residue. Such ‘loss of function’ or ‘nonsense’ variants may exert functional
effects at either the transcript level, via haploinsufficiency mechanisms, or at the protein level,
via truncation mechanisms. Haploinsufficiency occurs when the mRNA transcript encoding a
nonsense allele is eliminated via nonsense mediated decay (NMD). The process of NMD, how-
ever, requires splice sites for the detection of premature stop codons and thus does not occur
on transcripts of intronless genes [51]; as ALDH1B1 is intronless NMD seems unlikely. Thus,
if this transcript is translated and the protein product does not invoke the unfolded protein
response, the loss of function allele of ALDH1B1 could result in loss of a sizeable portion of the
final enzyme product encompassing the C-terminal 139 amino acids. This region of the pro-
tein contains the enzyme’s catalytic residues and may also be important for tetramer forma-
tion. Hence, an ALDH1B1 protein truncated at position 378 would likely be non-functional.
Clearly experimental studies would greatly facilitate functional understanding of this variant.
Despite the strength of evidence, from the bioinformatic analyses, for the presence of poten-
tially damaging functional mutations in ALDH1B1, these coding variants were not significantly
associated with alcohol dependence per se in a large well-characterized population of alcohol
dependent cases and controls of British and Irish ancestry. However, the prevalence of the
378STOP allele in rs142427338 (Gln378Ter) was higher in cases than in controls although the
difference was not significance. The MAFs of the three missense variants ranged from 4.6% to
40.9% and hence this study was sufficiently powered to detect significance between cases and
controls. However, the stop gain variant is very rare with a MAF of 0.01; thus this study was
likely underpowered to detect genetic association at the current sample size [52].
There are very few genetic association data available for comparison. Sherman et al. [20],
found no association between carriage of either rs2073478 or rs2228093 and alcohol dependence
risk in a cohort of 40 people of British ancestry genotyped using PCR-RFLP. Unfortunately, the
ALDH1B1 and alcohol dependence risk in a British and Irish population
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size of this population severely limits the statistical power at the expected effect size [53]. Addi-
tionally, the MAFs reported by Sherman et al [20] were notably different from those in the pres-
ent study viz 29% and 41% respectively for rs2073478 and 24% and 13.3% respectively for
rs2228093; this may reflect inaccuracies in the calculation of the population MAF due to the
small size of the cohort and/or to inaccuracies arising from use of PCR-RFLP genotyping, which
is prone to partial digestion and genotype reading errors [54]. However, the present study is suf-
ficiently powered to allow confidence in the concordant, negative association [52].
The relationships between polymorphisms in ALDH1B1 and alcohol drinking levels in the
general population and alcohol-related hypersensitivity reactions have been examined in two
large populations of Danish residents of Northern European origin [23–25]. The reported
MAFs for the two SNPs examined were similar to those in the present study viz 39% and 41%
respectively for rs2073478 and 12% and 13% respectively for rs2228093; thus the studies can be
usefully compared.
In the first Danish study Husemoen et al. [23] obtained self-reported information on alco-
hol consumption from 1216 participants in the population-based Copenhagen Allergy Study
and reported that carriage of the minor allele of rs2228093 was associated with non-drinking
and higher weekly alcohol intake; these findings are paradoxical as the same directionality of
allele effect between these related phenotypes would be expected.
In the second study, Linneberg et al. [25] combined the information on alcohol consump-
tion obtained from their original cohort of 1216 with similarly collected information from an
additional 6784 participants in a replication study. In addition they obtained self-reported
information on alcohol hypersensitivity and allergic rhinitis from 957 (79%) of the original
1216 participants and 2419 (36%) of the 6784 replication cohort. In the combined population,
carriers of the minor allele of rs2228093 reported significantly higher total alcohol consump-
tion and an increased prevalence of alcohol hypersensitivity; this finding is again paradoxical
as one would expect alcohol hypersensitivity to be associated with lower total alcohol con-
sumption and thus expect a common risk allele between phenotypes. It is unclear why this
apparent paradoxical effect occurs, although it is possible that the reported allergic reactions
may have been too mild to warrant avoidance of alcohol. However, quantitative information
on the severity of the response was not made available.
Emerging evidence suggests that rs2228093 has been under positive selection in East-Asian
populations over the past 10,000 years [55]. Wang et al. [55] showed that several functional
SNPs in alcohol metabolizing genes viz rs1229984 (ADH1B), rs671 (ALDH2), rs8187929
(ALDH1A1), rs3813867 (CYP2E1) and rs2031920 (CYP2E1), have been under moderate to
strong selection, which appears to have been driven by the expansion of agriculture. Although
these findings are not directly related to alcohol use phenotypes per se, they highlight the inter-
related function of alcohol metabolizing genes and in particular the shared factors influencing
allele frequencies in these populations. If selection pressures aresimilarly influencing these
genes in Europeans, then it is possible that the resultant effects could confound genetic associa-
tion studies of ALDH1B1, potentially explaining the negative findings observed in the present
study and the paradoxical findings observed by the Danish groups [23,25]
Conclusion
In conclusion: bioinformatic techniques have been used to investigate missense SNPs in
ALDH1B1, in particular the 86Val allele of rs2228093, which is predicted to disrupt the struc-
tural flexibility of the protein product, the enzyme ALDH1B1. If, as indicated from the bioin-
formatic data, these changes influence NAD binding to the catalytic domain of the enzyme, or
oligomerization between the enzyme subunits, then they could alter enzyme activity.
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Functional and molecular cloning studies would be needed to further elucidate the effects of
these polymorphisms and, in particular, their physiological role in alcohol pharmacokinetics.
Although no genetic associations were identified between the four selected SNPs in ALDH1B1
and alcohol dependence, the study was likely underpowered in relation to the stop gain variant
rs142427338 due to its rarity in this population. Exploration of these ALDH1B1 variants within
other European populations is clearly warranted.
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